Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs
Haacke, H.; Kolenda, K.D.
Medizinische Klinik 71(12): 513-517
1976
ISSN/ISBN: 0025-8458 PMID: 1263999 Document Number: 105525
Document emailed within 1 workday
Related Documents
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Palmer, J.D.; Bressler, R. 1974: Drug--drug interactions. A general discussion about how and where drugs may interact in the body Arizona Medicine 31(2): 89-93
Kigen, G.; Kimaiyo, S.; Nyandiko, W.; Faragher, B.; Sang, E.; Jakait, B.; Owen, A.; Back, D.; Gibbons, S.; Seden, K.; Khoo, S.H.; Nyandiko, W.; Wools-Kaloustian, K.; Kimaiyo, S.; Braitstein, P.; Sang, E.; Jakait, B.; Pastakia, S. 2011: Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort Plos one 6(2): E16800
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Steitz, A.M. 1986: Drugs--drug interactions Connecticut Medicine 50(3): 153-157
Finkel, M.J. 1972: Antilipemic drugs and the position of the FDA Advances in experimental medicine and biology 26(0): 263-265
Sawada, Y.; Satoh, H. 2012: Drug interactions of psychotropic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 70(1): 27-41
Pfeifer, S. 1995: Pharmacokinetic drug interactions. Part 3: Drugs P-Z Die Pharmazie 50(5): 307-332
Prokes, M.; Suchopár, J. 2009: Drug interactions of selected drugs used by patients with diabetes mellitus Vnitrni Lekarstvi 55(4): 395-402
Viramontes-Madrid, J.é L.; Jerjes-Sánchez, C.; Pelaez-Ballestas, I.; Aguilar-Chiu, A.; Hernández-Garduño, A.G. 2002: Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 54(3): 192-197
Moshkova, L.V.; Kumanina, N.P.; Korzhikova, E.B.; Sapegina, L.P. 1990: The information system "Interactions of drugs" and its role in drug therapy Sovetskoe Zdravookhranenie 2: 26-28
Voigt, R.; Thomas, G. 1983: Effects of the pH value and of drug-adjuvant interactions on the dissolution rate and the liberation of drugs Die Pharmazie 38(3): 183-186
Schäfer-Korting, M. 2003: New systemic antifungal drugs: mechanisms of action, drug interactions and side effects Mycoses 46(Suppl): 28-31
Wang, Y.; Zhou, C. 1999: Advances in the study of antilipemic action of Chinese herbal drug Zhongguo Zhong Yao Za Zhi 24(3): 184-186
Dalmau Serra, J. 1991: Drug therapy of hyperlipoproteinemias Anales Espanoles de Pediatria 35(Suppl 45): 20-21
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Tsuchiya, M.; Kawamura, J. 1975: Changes of plasma lipid levels in patients undergoing long-term hemodialysis--with special reference to the effects of antilipemic drugs and fatty acid emulsion Nihon Jinzo Gakkai Shi 17(4): 195-207
Neubert, R.; Fritsch, B.; Dongowski, G. 1995: Interactions between food components and drugs. Part 3. Interactions between pectin and propranolol Die Pharmazie 50(6): 414-416